Rare Diseases Creating Insight into General Health: Learn More at London Conference
SMi reports: According to Rare Disease UK, research and development in the area of rare diseases can often provide further understanding and insight into more common diseases.
SMi is proud to be hosting its 3rd annual Orphan Drugs and Rare Diseases conference on October 20th and 21st in London. This event will provide a platform for all stakeholders, inclusive of small biotechs, pharmaceutical companies, patient advocacy organisations, researchers and regulators to share perspectives and expertise to drive the field of Orphan Drugs and Rare Diseases forward.
Benefits of Attending 2014 Orphan Drugs and Rare Diseases Conference:
· Hear important insights from Daniel O’Connor, Medical Assessor, MHRA on the Early Access to Medicines Initiative and adaptive licensing
· Focus on enhancing development pathways, with the growth of the commercial pipeline for orphan drugs and rare diseases
· Assess tools for consideration to gain early market access and enhance patient recruitment
· Interactive round table discussion led by Dominic Nutt, Director of Communications, The Saatchi Cancer Initiative, M&C Saatchi on creating a culture of innovation in the field of orphan drugs and rare diseases
For more information please visit http://www.smi-
If you would like to attend this conference please contact Dayo Adejuwon on +44 (0) 207 827 6070 or email dadejuwon@smi-
+44 (0) 20 7827 6070